Search results
Results from the WOW.Com Content Network
The California End of Life Option Act was signed into law by Governor Jerry Brown on October 5, 2015, with Brown taking the unusual step of releasing a personal statement in which he indicated his dilemma regarding the consideration of the ethical issues involved and that he felt unable to deny the right of choice to others. [2] [12]
0.5–1 mg/day: 1–2 mg/day: 2–4 mg/day Estradiol valerate: 0.5–1 mg/day: ... Template:Estrogen dosages for breast and prostate cancer; Template:Medications and ...
25–50 mg/day Enzalutamide: Xtandi: Antiandrogen: Oral: 160 mg/day GnRH analogue: Various: GnRH modulator: Various: Variable Elagolix: Orilissa: GnRH antagonist: Oral: 150 mg/day or 200 mg twice daily Finasteride: Propecia: 5αR inhibitor: Oral: 1–5 mg/day Dutasteride: Avodart: 5αR inhibitor: Oral: 0.25–0.5 mg/day Progesterone: Prometrium ...
It applies to companies with 50 or more employees (unlike 100 for the federal law) where either 25 (50 for the federal law) or more workers are affected, if that number makes up at least 33% of the workers on that site. NY WARN Act requires a 90-day notice from the employer, unlike the federal Act that requires a 60-day notice. [6]
In California, minimum coverage car insurance requirements are 30/60/15 effective Jan. 1, 2025. Utah minimum coverage limits will increase to 30/60/25. Virginia limits will be 50/100/25.
This template's initial visibility currently defaults to autocollapse, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible. To change this template's initial visibility, the |collapse_state= parameter may be ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
Cyproterone acetate (CPA), sold alone under the brand name Androcur or with ethinylestradiol under the brand names Diane or Diane-35 among others, is an antiandrogen and progestin medication used in the treatment of androgen-dependent conditions such as acne, excessive body hair growth, early puberty, and prostate cancer, as a component of feminizing hormone therapy for transgender individuals ...